Room 213 A

Next Generation Biomaterial and Drug Delivery Technologies for Wound Healing

Wound healing is a significant clinical problem and a hot area in development of biomaterial and drug delivery technologies. This session requests abstracts on promising new wound care technologies, preferably those that have undergone in vivo preclinical testing and/or early clinical trials. Topics of interest include devices, matrices / dressings / scaffolds, and cell / drug / gene therapies. Abstracts related to material biocompatibility and therapies focused on harnessing and/or modulating the immune response within wounds are especially sought.

Biomimetic Materials for Tissue Engineering 2

Recently, biomaterial scientists have added bioactivity to their design toolbox in the development of new materials. These advanced biomaterials add another dimension of guided interaction with the body by mimicking the native remodeling processes (e.g., biological recognition, adhesion sites, substrate-dictated differentiation or cell-guided enzymatic degradation).

Injectable Biomaterials for Tissue Regeneration

The development of injectable biomaterials is attractive because these materials are performed in a minimally invasive manner which significantly accelerates wound healing, improves patient comfort and satisfaction. As a cell carrier, the injectable biomaterials can readily fit any irregular shapes of defects. When they act as a drug carrier, the injectable biomaterials can modulate temporal- and spatial-release of drugs to control cellular response in focal areas.

Materials and Matrices for Osteochondral Tissue Engineering

Osteochondral tissue comprises of bone and cartilage layers separated by a seamless interface. Engineering osteochondral tissue is challenging, as one needs to develop biomaterials and matrix systems that support the regeneration of a complex and well-structured osteochondral tissue. Mono-layered and bi-layered scaffolds have shown some promise in the beginning, however current efforts are focused to design gradiently structured scaffolds or the scaffolds with gradient growth factor profiles.

Cardiovascular Biomaterials 2

Biomaterials play an important role in the design and fabrication of a broad range of cardiovascular medical devices. New materials and applications are constantly developed in academia and research and development laboratories all over the world. The sessions will review current state-of-the-art devices and highlight key challenges involved in the development of cardiovascular biomaterials.

Biofabrication and Biomanufacturing in Tissue Engineering and Regenerative Medicine (TERM) 2

Biofabrication has become an innovative tool for the field of biomedical applications, especially, tissue engineering and regenerative medicine. This technology has been developed to allow construction of biological substitutes mimicking structures and functions of native tissues or organs. Biofabrication enables precise placement of various cell types, biomaterials, and bioactive molecules in a single three-dimensional (3-D) architecture.

Multiscale Biomaterial Design

Nano and Micro printing of biomaterials to engineer cells and their microenvironment involves fabrication of devices via methods such as rapid prototyping and use of biological model systems such as synthetic bacterial surface layers. The multiscale response of the cells from nano to micro to macro can be modulated for large scale biomanufacturing.

Biomaterial Degradation Analysis

Biomaterial degradation is a critical concern for any medical device whether it is preventing degradation of implantable devices or predicting the rate of degradation of drug releasing particles or tissue engineering scaffolds. Researchers often use accelerated in vitro testing to predict long term in vivo behavior; however, there are several pitfalls that can lead to incorrect conclusions about how a device will perform after implantation.